California governor says state won't do business with Walgreens over position on abortion pill - CNBC

erotoko.blogspot.com

California Gov. Gavin Newsom successfully quashed a recall attempt last year in California. Asked if he's getting ready for a presidential run, Newsom insisted that was not the case.

Justin Sullivan | Getty Images

California Gov. Gavin Newsom on Monday said the state would no longer do business with Walgreens, after the drugstore chain told 21 Republican attorneys general that it would not sell the abortion pill in their states.

Newsom said on Twitter that the state is "done" doing business with Walgreens. Brandon Richards, a spokesperson for the governor, said California is reviewing all relationships between Walgreens and the state.

"We will not pursue business with companies that cave to right wing bullies pushing their extremist agenda or companies that put politics above the health of women and girls," Richards said.

Walgreens declined to comment.

The Food and Drug Administration in January allowed retail pharmacies to sell the abortion pill, mifepristone, if they are certified under an agency program that monitors how the medication is used and distributed.

Walgreens plans to become certified to sell mifepristone where it is legal to do so under state and federal law, the company has said. In February, 21 Republican attorneys general warned Walgreens against mailing mifepristone in their states.

Join CNBC's Healthy Returns on March 29th, where we'll convene a virtual gathering of CEOs, scientists, investors and innovators in the health care space to reflect on the progress made today to reinvent the future of medicine. Plus, we'll have an exclusive rundown of the best investment opportunities in biopharma, health-tech and managed care. Learn more and register today: http://bit.ly/3DUNbRo

The company told the attorneys general that it would not sell or mail the pill in their states. Politico first reported the news.

Mifepristone, used in combination with another drug called misoprostol, is the most common method to terminate a pregnancy in the U.S., accounting for about half of all abortions.

CNBC Health & Science

Read CNBC's latest global health coverage:

• FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
• Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance
• FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risks
• Novavax raises doubts about its ability to remain in business
• Op-ed: DEA and FDA rules exacerbate Adderall shortage
• Democratic attorneys general sue FDA to drop all remaining restrictions on abortion pill
• FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults
• Medicare rejects Alzheimer’s Association request for unrestricted coverage of treatments like Leqembi
• Moderna misses on earnings as costs rise from surplus production capacity, lower demand for Covid shots
• West Virginia asks judge to dismiss lawsuit seeking to overturn state restrictions on abortion pill
• CDC advisors recommend mpox vaccine for at-risk adults in future outbreaks
• Flu vaccine was 68% effective at preventing hospitalization in children, but less protective for seniors this season
• Pfizer RSV vaccine that protects infants could receive FDA approval this summer
• Senators call on Medicare to offer broad coverage of Alzheimer’s treatments as public pressure grows
• Maker of promising Alzheimer’s drug Leqembi expects full FDA approval this summer, expanded Medicare coverage

Mifepristone has become a central focus in the battle over abortion access in the wake of the Supreme Court ruling that overturned Roe v. Wade last June.

A group of physicians who oppose abortion have asked a federal court in Texas to suspend the FDA's approval of mifepristone. Democratic attorneys general, on the other hand, have asked a federal court in Washington to declare the remaining FDA restriction's on mifepristone unconstitutional.

The FDA approved mifepristone more than two decades ago, but the agency imposed restrictions to ensure the pill's safe use. The agency has gradually eased those restrictions over the years as more evidence on its safety and efficacy has come in.

The agency did away with a requirement that patients obtain the pill in person at certain health-care facilities and allowed the medication to be sent by mail. Patients still need a prescription from a health-care provider that's certified with the FDA.

Adblock test (Why?)

"with" - Google News
March 07, 2023 at 04:55AM
https://ift.tt/s2LrHGW

California governor says state won't do business with Walgreens over position on abortion pill - CNBC
"with" - Google News
https://ift.tt/CsGRv4c
https://ift.tt/w9FlNTr

Bagikan Berita Ini